Gene therapy aims to treat disorders by replacing or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo).
This report contains market size and forecasts of Cell and Gene Therapy Manufacturing Services in Global, including the following market information:
Global Cell and Gene Therapy Manufacturing Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell and Gene Therapy Manufacturing Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
By Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell and Gene Therapy Manufacturing Services include Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza, Catalent, WuXi AppTec, Takara Bio Inc, Nikon Corporation and FUJIFILM Holdings Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell and Gene Therapy Manufacturing Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell and Gene Therapy Manufacturing Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, by Type, 2021 (%)
By Cell Therapy
Allogeneic
Autologous
Viral Vector
By Gene Therapy
Non-viral Vector
Oligonucleotides
Viral Vector
Global Cell and Gene Therapy Manufacturing Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, by Application, 2021 (%)
Oncology Diseases
Cardiovascular Diseases
Orthopedic Diseases
Ophthalmology Diseases
Infectious Diseases
Others
Global Cell and Gene Therapy Manufacturing Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell and Gene Therapy Manufacturing Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cell and Gene Therapy Manufacturing Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Merck KGaA
Charles River Laboratories
Lonza
Catalent
WuXi AppTec
Takara Bio Inc
Nikon Corporation
FUJIFILM Holdings Corporation
F. Hoffmann-La Roche
Oxford Biomedica Plc
Cell and Gene Therapy Catapult
The Discovery Labs LLC
RoslinCT
JRS PHARMA
FinVector
ABL
Resilience
BioCentriq
Porton Biopharma Limited
Andelyn Biosciences
Commercializing Living Therapies
Vibalogics
Anemocyte Srl
ElevateBio